Medication info
Kegrel Tablet (Clopidogrel Sulfate)

Kegrel Tablet (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201402838 · Approved 2014.06.25 · Insurance code 647203680

Summary

Main use
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly once daily. 3. For patients with atrial fibrillation, administer 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly once daily. Patients with renal impairment: Treatment experience in patients with renal impairment is limited. Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This drug is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also improves atherosclerotic symptoms such as mortality, myocardial infarction, and stroke in adult patients with acute coronary syndrome due to cardiovascular abnormalities. This drug helps reduce the risk of stroke and thromboembolism in adult patients with atrial fibrillation who have one or more vascular risk factors, are unsuitable for vitamin K antagonist use, and have a low risk of bleeding. Overall, this drug is effective in reducing the risk and improving symptoms of cardiovascular and cerebrovascular diseases.

How to take

Adult dose

Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be administered concomitantly once daily. 3. For patients with atrial fibrillation, administer 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly once daily. Patients with renal impairment: Treatment experience in patients with renal impairment is limited. Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This drug prevents blood clotting to prevent thrombus formation. Since this drug must be converted to its active form in the liver to be effective, individuals with genetically reduced function of the liver enzyme CYP2C19 may experience decreased efficacy. Therefore, in such cases, it is advised to change the treatment method or use other medications. Additionally, co-administration with drugs that activate CYP2C19 may increase the active metabolite concentration of this drug, raising the risk of bleeding, so concomitant use should be avoided. This drug should not be used in certain patients. For example, individuals allergic to this drug or its components, those with bleeding, individuals with severely impaired liver function, nursing mothers, and those with genetic issues such as lactose intolerance should not take this medication. Caution should be exercised when this drug is used in patients at high risk of bleeding. Especially if bleeding symptoms are suspected, a blood test should be performed immediately, and concurrent use with anticoagulants like warfarin may further increase the risk of bleeding, so care is needed. Patients scheduled for surgery should discontinue this drug 5 to 7 days before the procedure and can resume after hemostasis. During the administration of this drug, attention should always be paid to bleeding symptoms, and greater caution is advised when taken with other medications that pose a bleeding risk. The use of aspirin concomitantly may increase the risk of bleeding, so the necessity and risks of such combinations should be carefully considered. This drug may cause various side effects such as bleeding, decreased blood cell count, gastrointestinal disturbances, and skin rashes. In particular, bleeding may present as serious forms such as gastrointestinal bleeding and intracranial hemorrhage, so if bleeding symptoms occur, immediate notification to healthcare personnel is required. The fetal risk during pregnancy has not been confirmed, but given the risk of bleeding during delivery, it is advisable to discontinue use 5 to 7 days before delivery. While nursing, this drug may be excreted in breast milk, so discussions with a physician regarding whether to continue breastfeeding or discontinue medication are warranted. The safety and efficacy in pediatric patients have not been established, so it is better not to use this drug in children. Elderly patients are at increased risk of bleeding due to decreased renal and liver function, so careful monitoring of the patient's condition is necessary during administration. Overdosage may cause prolonged bleeding times and complications related to bleeding, and as there is no specific antidote, treatment may involve platelet transfusion if necessary. This drug should be stored out of reach of children, and care should be taken as transferring it to another container may compromise its quality.

Side effects

  • Bleeding
  • gastrointestinal bleeding
  • bleeding requiring hospitalization
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematuria
  • intraocular bleeding
  • intracranial bleeding
Show 127 more
  • major bleeding
  • life-threatening bleeding
  • fatal bleeding
  • hemorrhagic stroke
  • need for transfusion
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • nausea
  • rash
  • pruritus
  • headache
  • dizziness
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • decreased motor function
  • tremor
  • voice disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • sensory disturbance
  • insomnia
  • depression
  • forgetfulness
  • anxiety
  • seizures
  • abnormal thoughts
  • abnormal behavior
  • arthralgia
  • myalgia
  • low back pain
  • weight loss
  • weight gain
  • facial flushing
  • weakness
  • rigidity
  • facial edema
  • syncope
  • purpura
  • melena
  • hematoma
  • gingival bleeding
  • pneumonia
  • sinusitis
  • visual disturbances
  • visual field defects
  • dry eye syndrome
  • transient blindness
  • congestion
  • tinnitus
  • dysuria
  • frequent urination
  • hypoglycemia
  • hyperuricemia
  • increased liver enzymes
  • elevated ALT
  • abnormal liver function
  • leg edema
  • arrhythmia
  • bradycardia
  • palpitations
  • contact dermatitis
  • gynecomastia
  • elevated prostate-specific antigen
  • allergy symptoms
  • ischemic necrosis
  • gastritis
  • hemorrhagic gastroenteritis
  • duodenal ulcer
  • gastric ulcer
  • perforated gastric ulcer
  • upper gastrointestinal ulcer bleeding
  • distension
  • hyperbilirubinemia
  • infectious hepatitis
  • fatty liver
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal bleeding
  • surgical wound bleeding
  • pulmonary hemorrhage
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • stomatitis
  • hepatitis
  • acute liver failure
  • papular eruption
  • erythematous skin rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • eczema
  • lichen planus
  • arthritis
  • glomerulopathy
  • gynecomastia
  • fever
  • abnormal liver function tests
  • increased serum creatinine
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air and moisture and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way can maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.